Europe’s healthcare regulator has endorsed the anti-viral drug Remdesivir as a treatment for Covid-19, putting it on track to be used in EU countries.
The European Medicines Agency (EMA) said on Thursday it had recommended the drug for use in adults and adolescents from 12 years of age with pneumonia who require oxygen support.
Remdesivir, which has been used against Ebola, is currently undergoing clinical trials around the world to better understand its effects.
UK regulators approved the drug for use in selected Covid-19 hospital patients at the end of May.
Remdesivir will need final approval from the European Commission before it can be prescribed in EU countries.
France President Macron Says Russia Must Answer For War Crimes In Bucha Ukraine 
Seven Countries Jointly Call On Taliban To Ensure Rights 
Two Russian soldiers killed and 28 ill ‘after being given poisoned food by Ukrainian civilians’ 
